Neonious Biotech

Neonious Biotech

Created using Figma
Neonious Biotech is introducing the Neonious Token (MDSIM) which is intended to
incentivize large numbers of people to form the Neonious Network, a group of
computers which will perform the molecular dynamics simulations, by distributing
newly generated MDSIMs among these people based on the computing power they
provide to the cause. With the molecular dynamics simulations, Neonious Biotech
will power Alzheimer and dementia research.
Pre-ICO
25.05.2021
31.10.2021
100% abgeschlossen
Geleistete Mittel - keine Daten
Ziel 250 000.00 USD
Limit 30 000 000.00 USD
past
  • 1 MDSIM
    =
    0.1 USD
Token-Details
Ticker
MDSIM
Gesamtangebot
125000000
Tokenverteilung
80% Token Sale
11% Token Sale Marketing
6% Scientific Advisors
3% Neonious Employees
Akzeptierte Währungen
ETH, USDC
Mindestbeitrag
250000
USD
Firmendetails
Registrierter Firmenname
Neonious Biotech
Eingetragenes Land
Germany
Bonusstruktur
The price per token starts at 0.10 USD and will, as a minimum, increase by 0.01 USD after every 250,000 ordered tokens, making it worthwhile to buy early.
Weitere Details
MVP / Prototyp
Ja
Plattform
Ethereum
Eingeschränkte Länder
Cuba, Iran, Lebanon, Libya, Syria, Sudan, Yemen
Kategorien
Plattform

Über Neonious Biotech

We are pioneers of in silico prediction of drug safety and adverse reactions, limiting cost risks and reducing harm done to animals and humans.

To have the best tools for our drug analysis, we constantly optimize algorithms and pipelines and grow our distributed network which is a cost-efficient source for the needed computing power.

Our research is powered by the Neonious Network
and the Neonious Token (MDSIM).

Neonious is contracted to help to assess a drug for safety and adverse reactions.

Besides manual analysis, Neonious' research team utilizes computational pipelines

These pipelines queue simulations (docking + MD) to be run by the Neonious Network, paid with MDSIMs.

Sombody running the Neonious software, thus being part of the Neonious Network, runs the simulations.

This person is rewarded with easy transferable MDSIMs, which he or her can exchange for real money.

We believe it is beneficial to reduce risks by contract us to analyse your drug, preferable before starting preclinical research, latest before phase 2 of the human trials.

For lower cost, we can utilize the Neonious Network. Alternatively, the calculations can also be done on more private computing resources

Technische Information

https://github.com/neonious/WelcomeToCodeRepository

Neonious Biotech Roadmap

  • 25/05/2021

  • Neonious Tokens can be ordered at the Neonious Biotech website. The earlier they are
    ordered, the cheaper the tokens are.
  • 01/07/2021

  • Extensively tested Neonious MD software available on GitHub (source code) and for
    download (Windows, macOS and Linux). May be used on testing network to generate new
    testing tokens.
  • 01/09/2021

  • Neonious MD software and mining contract passed security audit, results are published.
    Neonious Biotech starts the full ICO, preferably with a major exchange.
  • 31/10/2021

  • Neonious Token sale ends. Neonious Biotech will enable trading of Neonious Tokens for
    anyone on Uniswap by setting up an adequate liquidity pool.
  • Weiterlesen
  • 01/11/2021

  • Neonious Biotech will start helping people set up their systems with the Neonious MD
    software to scale the Neonious Network.
  • 01/01/2022

  • Start of actual molecular dynamic simulations targeting dementia.
  • Early 2022

  • We plan to have reached an agreement for the Neonious Token to be listed at a major
    exchange.

Neonious Biotech Mannschaft

Verifiziert 0%

Beachtung. Es besteht das Risiko, dass nicht verifizierte Mitglieder nicht Mitglieder des Teams sind

Thomas Rogg
Chief Executive Officer & Head of Development Team
unbestätigt
Elena Elgina
Head of PR & Marketing
unbestätigt
Maria Cristina Fadgy...
Head of Scientific Affairs
unbestätigt
Martin Kämpf
Head of Digital Assets
unbestätigt

Neonious Biotech Letzte Nachrichten

  • Da bei der Aktualisierung von Informationen zeitliche Unterschiede auftreten können, sollten genaue Informationen zu jedem ICO-Projekt über die offizielle Website oder andere Kommunikationskanäle überprüft werden.
  • Diese Informationen sind kein Vorschlag oder Ratschlag für Investitionen in die ICO-Finanzierung. Bitte recherchieren Sie die relevanten Informationen gründlich und entscheiden Sie sich für die Teilnahme von ICO.
  • Wenn Sie der Meinung sind, dass Probleme oder Probleme bei diesem Inhalt behoben werden müssen, oder wenn Sie Ihr eigenes ICO-Projekt zur Aufnahme einreichen möchten, senden Sie uns bitte eine E-Mail.
Bitte lesen Sie den Haftungsausschluss und die Risikowarnung. Zeige Disclaimer und Risikowarnung.